Covered recipient · General Payments record
EDWARD L VOLLRATH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$627.42
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.22 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $65.77 | 3 |
| GlaxoSmithKline, LLC. | $53.69 | 3 |
| Novo Nordisk AS | $37.52 | 2 |
| Dynavax Technologies Corporation | $23.75 | 1 |
| DEXCOM, INC. | $18.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.45 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125325256 | CMS |
| Abbott Laboratories | $25.36 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125325258 | CMS |
| Abbott Laboratories | $15.96 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125325260 | CMS |
| Dexcom, Inc. | $18.49 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153297714 | CMS |
| Dynavax Technologies Corporation | $23.75 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082150527 | CMS |
| GlaxoSmithKline, LLC. | $16.04 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116599073 | CMS |
| GlaxoSmithKline, LLC. | $18.37 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116446388 | CMS |
| GlaxoSmithKline, LLC. | $19.28 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116438791 | CMS |
| Novo Nordisk Inc | $18.30 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097523482 | CMS |
| Novo Nordisk Inc | $19.22 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096905583 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.